|
1
|
Grommes C and DeAngelis LM: Primary CNS
lymphoma. J Clin Oncol. 35:2410–2418. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Villano JL, Koshy M, Shaikh H, Dolecek TA
and McCarthy BJ: Age, gender, and racial differences in incidence
and survival in primary CNS lymphoma. Br J Cancer. 105:1414–1418.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hoffman S, Propp JM and McCarthy BJ:
Temporal trends in incidence of primary brain tumors in the United
States, 1985-1999. Neuro Oncol. 8:27–37. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Montesinos-Rongen M, Brunn A, Bentink S,
Basso K, Lim WK, Klapper W, Schaller C, Reifenberger G, Rubenstein
J, Wiestler OD, et al: Gene expression profiling suggests primary
central nervous system lymphomas to be derived from a late germinal
center B cell. Leukemia. 22:400–405. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Camilleri-Broët S, Criniè E, Broët P,
Delwail V, Mokhtari K, Moreau A, Kujas M, Raphaël M, Iraqi W,
Sautès-Fridman C, et al: Auniform activated B-cell-like
immunophenotype might explain the poor prognosis of primary central
nervous system lymphomas: Analysis of 83 cases. Blood. 107:190–196.
2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bhagavathi S and Wilson JD: Primary
central nervous system lymphoma. Arch Pathol Lab Med.
132:1830–1834. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shiels MS, Pfeiffer RM, Besson C, Clarke
CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G and Engels
EA: Trends in primary central nervous system lymphoma incidence and
survival in the U.S. Br J Haematol. 174:417–424. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Correa DD, DeAngelis LM, Shi W, Thaler H,
Glass A and Abrey LE: Cognitive functions in survivors of primary
central nervous system lymphoma. Neurology. 62:548–555.
2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Batchelor T and Loeffler JS: Primary CNS
lymphoma. J Clin Oncol. 24:1281–1288. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
van der Meulen M, Dirven L, Habets EJJ,
van den Bent MJ, Taphoorn MJB and Bromberg JEC: Cognitive
functioning and health-related quality of life in patients with
newly diagnosed primary CNS lymphoma: A systematic review. Lancet
Oncol. 19:e407–e418. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Doolittle ND, Korfel A, Lubow MA, Schorb
E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF,
et al: Long-term cognitive function, neuroimaging, and quality of
life in primary CNS lymphoma. Neurology. 81:84–92. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Thiel E, Korfel A, Martus P, Kanz L,
Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T,
Hundsberger T, et al: High-dose methotrexate with or without whole
brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): A phase
3, randomised, non-inferiority trial. Lancet Oncol. 11:1036–1047.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sierra del Rio M, Rousseau A, Soussain C,
Ricard D and Hoang-Xuan K: Primary CNS lymphoma in immunocompetent
patients. Oncologist. 14:526–539. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Fritsch K, Kasenda B, Schorb E, Hau P,
Bloehdorn J, Möhle R, Löw S, Binder M, Atta J, Keller U, et al:
High-dose methotrexate-based immuno-chemotherapy for elderly
primary CNS lymphoma patients (PRIMAIN study). Leukemia.
31:846–852. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Batchelor T, Carson K, O'Neill A, Grossman
SA, Alavi J, New P, Hochberg F and Priet R: Treatment of pimary CNS
lymphoma with methotrexate and deferred radiotherapy: A report of
NABTT 96-07. J Clin Oncol. 21:1044–1049. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hoang-Xuan K, Taillandier L, Chinot O,
Soubeyran P, Bogdhan U, Hildebrand J, Frenay M, De Beule N,
Delattre JY and Baron B: European Organization for Research and
Treatment of Cancer Brain Tumor Group. Chemotherapy alone as
initial treatment for primary CNS lymphoma in patients older than
60 years: A multicenter phase II study (26952) of the European
Organization for Research and Treatment of Cancer Brain Tumor
Group. J Clin Oncol. 21:2726–2731. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Abrey LE, Batchelor TT, Ferreri AJ,
Gospodarowicz M, Pulczynski EJ, Zucca E, Smith JR, Korfel A,
Soussain C, DeAngelis LM, et al: Report of an international
workshop to standardize baseline evaluation and response criteria
for primary CNS lymphoma. J Clin Oncol. 23:5034–5043.
2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
DeAngelis LM, Seiferheld W, Schold SC,
Fisher B and Schultz CJ: Radiation Therapy Oncology Group Study
93-10. Combination chemotherapy and radiotherapy for primary
central nervous system lymphoma: Radiation Therapy Oncology Group
Study 93-10. J Clin Oncol. 20:4643–4648. 2002.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shah GD, Yahalom J, Correa DD, Lai RK,
Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM and Abrey LE:
Combined immunochemotherapy with reduced whole-brain radiotherapy
for newly diagnosed primary CNS lymphoma. J Clin Oncol.
25:4730–4735. 2007.PubMed/NCBI View Article : Google Scholar
|
